Article ID Journal Published Year Pages File Type
10968745 Vaccine 2011 4 Pages PDF
Abstract
► A new recombinant 30-valent M protein-based group A streptococcal vaccine. ► Vaccine design based on current epidemiology of pharyngeal and invasive infections. ► Bactericidal antibodies evoked against all vaccine serotypes of streptococci. ► Vaccine antisera were bactericidal against a number of non-vaccine serotypes.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology
Preview
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci
Authors
, , , ,